Nasal Allergy Treatments
Current guidelines recommend intranasal corticosteroids and nasal irrigation as first line therapies for AR and ARS. Additional therapeutic options may involve intranasal or systemic antihistamine treatments, leukotriene antagonists, systemic corticosteroids, immunotherapy and biological therapies, as well as surgery. Table 2 summarises research findings from AR/ARS treatment studies which report throat symptoms as primary or secondary treatment outcomes, as well as relevant recommendations derived from consensus guidelines. In general, this literature is sparse and challenging to identify, with dominant consideration given to cough within the UACS context. Some data indicates that patients with AR may benefit from additional adjunct treatment strategies additional to intranasal corticosteroids in order to maximally address additional throat complaints, including antihistamines and leukotriene antagonists, though insufficient evidence is identified to provide recommendations. The role of immunotherapy and other novel allergy treatment strategies for this purpose remains uncertain without research attention.